Form 4: Inovio Pharmaceuticals Director Ann Calby Miller Reports Stock Transaction

Director Ann Calby Miller reports the vesting and acquisition of 2,166 shares of Inovio Pharmaceuticals common stock on May 15, 2024, related to restricted stock units.

Summary

• On May 15, 2024, Ann Calby Miller, a director of Inovio Pharmaceuticals, acquired 2,166 shares of common stock.
• The acquisition resulted from the vesting of restricted stock units.
• These restricted stock units vested 100% on May 15, 2024, with each unit representing a contingent right to receive one share of common stock.
• The reported transaction gives effect to a 1-for-12 reverse stock split that Inovio Pharmaceuticals implemented on January 24, 2024.
• Following the transaction, Miller directly owns 7,710 shares of Inovio Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing regarding a stock transaction, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure of a director's stock transaction and doesn't necessarily indicate a broader trend within the pharmaceutical industry.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the change in ownership, but it is unlikely to be significant.

Key Dates